Cipla Limited Cipla Limited

Cipla Limited

CIPLA

Pozycja w akcjach #1810
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Cena akcji
$14.61
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$11.81B
Zmiana (1 dzień)
-0.11%
Zmiana (1 rok)
-21.65%
Kraj
IN
Handel Cipla Limited (CIPLA)

Kategoria

Healthcare
Historia podziałów akcji dla Cipla Limited (CIPLA)
Akcje Cipla Limited (symbol: CIPLA) przeszły łącznie 4 podziałów.
Najnowszy podział miał miejsce Apr 24, 2006.
Jedna akcja CIPLA kupiona przed Oct 18, 1999 odpowiada dziś 112.5 akcjom CIPLA.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
2006-04-24 5:2 x2.5 x112.5
2004-05-11 5:1 x5 x45
1999-10-21 3:1 x3 x9
1999-10-18 3:1 x3 x3
Podziały akcji dla podobnych firm lub konkurencji